Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeremy Teoh

Showing results (21-30 of 57) with videos related to

Pageof 6
Sort By:
Journal of Integrative Medicine|September 25, 2019
Factors influencing communication of traditional Chinese medicine use between patients and doctors: A multisite cross-sectional studyWen Qiang Lee, Jeremy Teoh, Pei Zheng Kenneth Lee, et al.
International Urology and Nephrology|February 26, 2022
Risks of metabolic diseases and androgen deprivation therapy for prostate cancer in a Chinese population: a prospective multi-centre cohort studyChris Wong, Peggy Chu, Jeremy Teoh, et al.
Prostate Cancer and Prostatic Diseases|September 2, 2024
Local salvage therapies in patients with radio-recurrent prostate cancer following external beam radiotherapy: a systematic review and meta-analysisMassimiliano Creta, Shahrokh F Shariat, Giancarlo Marra, et al.
World Journal of Urology|August 7, 2024
Does concordance between preoperatively measured prostate volume and enucleated weight predict outcomes in endoscopic enucleation of the prostate? Results from the REAP databaseKhi Yung Fong, Vineet Gauhar, Daniele Castellani, et al.
Prostate Cancer and Prostatic Diseases|January 10, 2024
A multi-center international study to evaluate the safety, functional and oncological outcomes of irreversible electroporation for the ablation of prostate cancerKai Zhang, Phillip Stricker, Martin Löhr, et al.
Annals of the Academy of Medicine, Singapore|December 8, 2021
Adverse reactions and safety profile of the mRNA COVID-19 vaccines among Asian military personnelJoshua T C Tan, Clive Tan, Jeremy Teoh, et al.
Cancers|July 12, 2025
Oncological and Functional Outcomes of Hemi-Ablation Versus Focal Ablation for Localized Prostate Cancer Using Irreversible ElectroporationMichel Suberville, Kai Zhang, Jean Baptiste Woillard, et al.
Nature Reviews. Urology|January 14, 2026
A multi-modal approach for decision making in bladder cancerHasan Al-Sattar, Hao Ding, Oluchi Okoli, et al.
European Urology Focus|May 3, 2022
Gender Disparities Among Editorial Boards of International Urology JournalsMadeleine L Burg, Tamir Sholklapper, Priya Kohli, et al.
Translational Andrology and Urology|March 14, 2022
ELIGANT: a Phase 4, interventional, safety study of leuprorelin acetate (ELIGARD<sup>®</sup>) in Asian men with prostate cancerRohan Malek, Sheng-Tang Wu, Dennis Serrano, et al.
Pageof 6

Showing results (21-30 of 57) with videos related to

Sort By:
Pageof 6
Journal of Integrative Medicine|September 25, 2019
Factors influencing communication of traditional Chinese medicine use between patients and doctors: A multisite cross-sectional studyWen Qiang Lee, Jeremy Teoh, Pei Zheng Kenneth Lee, et al.
International Urology and Nephrology|February 26, 2022
Risks of metabolic diseases and androgen deprivation therapy for prostate cancer in a Chinese population: a prospective multi-centre cohort studyChris Wong, Peggy Chu, Jeremy Teoh, et al.
Prostate Cancer and Prostatic Diseases|September 2, 2024
Local salvage therapies in patients with radio-recurrent prostate cancer following external beam radiotherapy: a systematic review and meta-analysisMassimiliano Creta, Shahrokh F Shariat, Giancarlo Marra, et al.
World Journal of Urology|August 7, 2024
Does concordance between preoperatively measured prostate volume and enucleated weight predict outcomes in endoscopic enucleation of the prostate? Results from the REAP databaseKhi Yung Fong, Vineet Gauhar, Daniele Castellani, et al.
Prostate Cancer and Prostatic Diseases|January 10, 2024
A multi-center international study to evaluate the safety, functional and oncological outcomes of irreversible electroporation for the ablation of prostate cancerKai Zhang, Phillip Stricker, Martin Löhr, et al.
Annals of the Academy of Medicine, Singapore|December 8, 2021
Adverse reactions and safety profile of the mRNA COVID-19 vaccines among Asian military personnelJoshua T C Tan, Clive Tan, Jeremy Teoh, et al.
Cancers|July 12, 2025
Oncological and Functional Outcomes of Hemi-Ablation Versus Focal Ablation for Localized Prostate Cancer Using Irreversible ElectroporationMichel Suberville, Kai Zhang, Jean Baptiste Woillard, et al.
Nature Reviews. Urology|January 14, 2026
A multi-modal approach for decision making in bladder cancerHasan Al-Sattar, Hao Ding, Oluchi Okoli, et al.
European Urology Focus|May 3, 2022
Gender Disparities Among Editorial Boards of International Urology JournalsMadeleine L Burg, Tamir Sholklapper, Priya Kohli, et al.
Translational Andrology and Urology|March 14, 2022
ELIGANT: a Phase 4, interventional, safety study of leuprorelin acetate (ELIGARD<sup>®</sup>) in Asian men with prostate cancerRohan Malek, Sheng-Tang Wu, Dennis Serrano, et al.
Pageof 6